XML 27 R17.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Note 11 - Capital Stock
9 Months Ended
Apr. 30, 2024
Notes to Financial Statements  
Equity [Text Block]

NOTE 11:

CAPITAL STOCK

 

Equity Financing

 

On May 17, 2021, we filed a Form S-3 shelf registration statement under the United States Securities Act of 1933, as amended (the “Securities Act”), which was declared effective by the SEC on June 1, 2021, providing for the public offer and sale of certain securities of the Company from time to time, at our discretion, of up to an aggregate offering amount of $200 million (the “2021 Shelf”), which included an at-the-market offering agreement prospectus (the “May 2021 ATM Offering”) covering the offering, issuance and sale of up to a maximum offering of $100 million as part of the $200 million under the 2021 Shelf.

 

On May 14, 2021, we entered into an at-the-market offering agreement (the “2021 ATM Offering Agreement”) with H.C. Wainwright & Co., LLC and certain co-managers (collectively, the “2021 ATM Managers”) as set forth in the 2021 ATM Offering Agreement under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $100 million through the 2021 ATM Managers selected by us.

 

On November 26, 2021, we filed a prospectus supplement to our 2021 Shelf with respect to the continuation of the May 2021 ATM Offering Agreement with the 2021 ATM Managers under which we may, if eligible, from time to time, sell shares of our common stock having an aggregate offering price of up to an additional $100 million for a total of $200 million through the 2021 ATM Managers selected by us (the “November 2021 ATM Offering”; and, collectively, with the May 2021 ATM Offering, the “2021 ATM Offering”).

 

On November 16, 2022, we filed a Form S-3 automatic shelf registration statement under the Securities Act, which became effective upon filing, providing for the public offer and sale of certain securities of the Company from time to time, at our discretion, of an undetermined dollar value of common stock, debt securities, warrants to purchase common stock or debt securities, subscription receipts for and units which include common stock, debt securities, warrants or any combination thereof (the “2022 Shelf”), which included an at-the-market offering agreement prospectus (the “2022 ATM Offering”; and, collectively, with the 2021 ATM Offering, the “ATM Offerings”) covering the offering, issuance and sale of up to a maximum offering of $300 million under the 2022 Shelf.

 

 

On November 16, 2022, we also entered into an at-the-market offering agreement (the “2022 ATM Offering Agreement”) with H.C. Wainwright & Co., LLC and certain co-managers (collectively, the “2022 ATM Managers”) as set forth in the 2022 ATM Offering Agreement under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $300 million through the 2022 ATM Managers selected by us.

 

During the three and nine months ended April 30, 2024, we issued 3,396,370 and 24,584,399 shares of the Company’s common stock under the ATM Offerings for net cash proceeds of $25,542 and $155,050, respectively.

 

Subsequent to April 30, 2024, we issued a further 1,791,300 shares of the Company’s common stock under our ATM Offerings for net cash proceeds of $12,824.

 

Share Purchase Warrants

 

A continuity schedule of our outstanding share purchase warrants for the three and nine months ended April 30, 2024, is as follows:

 

  

Number of

  

Weighted Average

 
  

Warrants

  

Exercise Price

 

Balance, July 31, 2023

  3,857,030  $3.31 

Exercised

  (1,452,914)  3.20 

Balance, April 30, 2024

  2,404,116  $3.38 

 

A summary of our share purchase warrants outstanding and exercisable as of April 30, 2024, is as follows:

 

    

Number of

  

Weighted Average Remaining

  

Weighted Average

  

Warrants

  

Contractual

  

Exercise Price

  

Outstanding

  

Life (Years)

 

Expiry Date

$3.32   2,222,298   0.36 

September 7, 2024

 4.13   181,818   1.93 

April 5, 2026

$3.38   2,404,116   0.48  

 

During the three and nine months ended April 30, 2024, we received cash proceeds of $3,771 and $4,508, respectively, from the exercise of share purchase warrants.

 

Subsequent to April 30, 2024, 39,393 warrants with an expiry date of September 7, 2024 were exercised and proceeds of $93 were received.